Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Metrovacesa S.A.
  6. News
  7. Summary
    MVC   ES0105122024

METROVACESA S.A.

(MVC)
  Report
Delayed Bolsas y Mercados Espanoles  -  11:38:00 2023-01-27 am EST
6.730 EUR   -1.61%
01/25Sanjose - Cartuja I. will build the Villas del Sena Residential Development in Seville
AQ
2022Sanjose - Cartuja I. will build the Medblue Los Monteros residential development in Marbella, Malaga
AQ
2022Metrovacesa S A : begins construction of Altos de Parque Serralta, a new housing complex in Barakaldo, Bizkaia
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Metrovacesa S A : Investor Presentantion

11/14/2022 | 10:35am EST

We build innovative

and sustainable housing,

unique and welcoming homes

where to live in

CORPORATE PRESENTATION. November 2022

Mesena 80 render (Madrid)

Disclaimer

This Presentation neither constitutes nor forms part of any offer for sale or invitation to purchase or subscribe for, or request for an offer of purchase or subscription, of the shares belonging to Metrovacesa, SA ("Metrovacesa"). This Presentation, as well as the information included therein, neither constitutes nor forms part of (i) any contract or commitment of purchase or subscription of shares in accordance with the Securities Market Law, or (ii) an offer of purchase, sale or exchange of shares, or a solicitation of any type of voting rights in the jurisdiction of Spain, UK, USA or any other. "Presentation" refers to this document and any part or content of this document; any oral presentation, brainstorming session and written or audio material processed or distributed during the meeting related to the Presentation or in any way associated with the Presentation. The Presentation and the information contained in the Presentation may not be reproduced, used, distributed or published, in whole or in part, in any case, except with regard to the information extracted from the Presentation and used for the preparation of analysts' reports in accordance with the applicable regulations. The breach of this obligation may result in a violation of the legislation applying to the securities market and this may lead to civil, administrative or criminal liability. In addition to information related to historical facts, this Presentation may contain forward-looking statements relative to Metrovacesa's sales and results and to other issues such as industry, business strategy, goals and expectations concerning its market position, future operations, margins, profitability, capital investment, own resources and other operational and financial information. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are not about historical facts. The terms "foresee", "expect", "anticipate", "estimate", "consider", "may" and other similar expressions may identify forward-looking statements. Other forward-looking statements can be identified based on their context. Forward-looking statements are based on numerous hypotheses and assumptions relating to Metrovacesa's present and future business strategy, as well as the environment in which Metrovacesa expects to operate in the future. Forward-looking statements include and involve known and unknown risks, uncertainties and other material factors that may affect the actual results and performance of Metrovacesa or the industry. Therefore, the result and the actual performance may differ materially from those expressed or implied in these statements. None of the forward-looking statements, expectations, or perspectives included in this Presentation should be construed as a prediction or a promise. Neither should it be understood that the forward-looking statements involve any demonstration, promise or warranty whatsoever of the accuracy or completeness of the assumptions or hypotheses which such forward-looking statements, expectations, estimates or forecasts are based on, or, in the case of the assumptions, their full inclusion in the Presentation. Numerous factors may cause Metrovacesa's results or actual performance to be materially different from any future results or performance expressly or implicitly included in any of the aforementioned forward-looking statements. In the event that one or several of the aforementioned risks or uncertainties were to materialise, or in the event that the assumptions prove incorrect, actual results may be materially different from those described, anticipated, expected or projected in the Presentation. Therefore, the recipient of this presentation should not unduly rely on these forward-looking statements and their ability to predict future outcomes. Present and future analysts, securities brokers and investors must operate based on their own judgement as to the suitability and adequacy of the securities in terms of the achievement of their particular goals, having taken into consideration what is specified in this notice and the public information available and having received all the professional advice, or of any other type, deemed necessary or merely convenient in these circumstances, without having relied solely on the information contained in the Presentation. The dissemination of this Presentation does not constitute advice or recommendation by Metrovacesa to buy, sell or trade with Metrovacesa shares, or with any other security. Analysts, securities brokers and investors should take into account that the estimates, projections and forecasts do not guarantee the performance, result, prices, margins, exchange rates and other facts relating to Metrovacesa, which are subject to risks, uncertainties or other variables that are not within Metrovacesa's control, in such a way that the future results and the actual performance could be materially different to that anticipated, projected and estimated. The information contained in this Presentation which is not intended to be all-inclusive, has not been verified by an independent third party and shall not be updated. The information of the Presentation, including the forward-looking statements, refers to the date of this document and does not imply any guarantee for future results. Metrovacesa expressly disclaims any obligation or undertaking to disseminate any updates or revisions of the information, including financial data and forward-looking statements. In this regard, Metrovacesa shall not publicly distribute any revision that may affect the information contained in the Presentation that is derived from changes in expectations, facts, conditions or circumstances on which is based the forward-looking statements, or any other change that occurred on the date of the Presentation or after this date. The data relating to the industry, the market and the competitive position of Metrovacesa contained in this Presentation that are not attributable to a specific source have been extracted from the analyses or estimates made by Metrovacesa and have not been independently verified. In addition, the Presentation may include information related to other companies operating in the same sector and industry. This information comes from public sources and Metrovacesa provides no express or implied representation or warranty, nor assumes any responsibility for the accuracy, completeness or verification of the aforementioned data. Certain statistical and financial information contained in the Presentation are subject to rounding adjustment. Therefore, any discrepancy between the total and the sum of the amounts reflected is due to this rounding off. Some of the indicators of financial and operational management included in this Presentation have not been subjected to a financial audit or verification by an independent third party. In addition, certain figures of the Presentation, which have not been subject to financial audit either, are pro forma figures. Metrovacesa and its employees, executives, directors, advisors, representatives, agents or affiliates assume no liability (for fault or negligence, direct or indirect, tort or contract) for damages that may arise from the use of this Presentation or its content or that, in any case, are related to this Presentation. The information contained in this Presentation does not constitute legal, accounting, regulatory, tax, financial or any other type of advice. The aforementioned information has not been prepared taking into consideration the needs or particular situations nor the investment, legal, accounting, regulatory, tax, or financial goals of the recipients of the information. Solely recipients shall be responsible for forming their own judgment and reaching their own opinions and conclusions with respect to these matters and the market, as well as for making an independent assessment of the information. Solely recipients shall be responsible for seeking independent professional advice in connection with the information contained in the Presentation and any action taken based on such information. No one takes responsibility for the information or for any actions taken by any recipient or any of its directors, executives, employees, agents or associates on the basis of the aforementioned information. Neither this presentation nor any part thereof are contractual in nature, and may not be used to form part of or constitute any kind of agreement. Upon receipt of or attendance to the Presentation, the recipient declares its conformity and, therefore, to be subject to the restrictions specified in the preceding paragraphs

2.

Agenda

Table of Contents

1. Executive summary

2. Business activity

  1. Corporate information
  2. Appendices

3.

Mirades (Terrassa, Barcelona)

1. Executive Summary

Metrovacesa

At a glance

MISSION

VISION

Creating homes to improve our clients' lives

Being the developer of choice for customers, employees, communities and shareholders

The largest land bank

GAV by use

GAV by land permitting

GAV by location

#1

among developers:

Commercial

Under

Fully-

Other

Madrid

Residential

permitting

25%

25%

permitted

26%

75%

homebuilding

€2,566m

17%

83%

operator in Spain

GAV Jun22

Barcelona

Balearics

19%

5%

c.30.5k

Valencia

Sevilla

Málaga

7%

residential units in land

6%

12%

Competitive

Access to land

Access to financing

Operational flexibility

strengths

In house land management team

Low LTV ratio of 5.9%

Varied client and segment profiles

Higher cashflow conversion

89% of the debt is fixed or hedged with

no significant maturities until 2026

Pre-sales backlog (units)

Under construction (units)

Under commercialisation (units)

4.007

5.440

5.555

5.774

3.033

3.047

5.378

3.550

2.567

3.393

3.441

Growth visibility

2.131

3.840

909

955

1.329

1.222

541

FY17

FY18

FY19

FY20

FY21

9M22

FY17

FY18

FY19

FY20

FY21

9M22

FY17

FY18

FY19

FY20

FY21

9M22

5.

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Metrovacesa SA published this content on 14 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2022 15:34:03 UTC.


© Publicnow 2022
All news about METROVACESA S.A.
01/25Sanjose - Cartuja I. will build the Villas del Sena Residential Development in Seville
AQ
2022Sanjose - Cartuja I. will build the Medblue Los Monteros residential development in Mar..
AQ
2022Metrovacesa S A : begins construction of Altos de Parque Serralta, a new housing complex i..
PU
2022Metrovacesa S A : starts the commercialization of the first phase of Mesena 80-82, in Artu..
PU
2022Metrovacesa S A : Investor Presentantion
PU
2022Metrovacesa S A : closes an agreement with Magno Living for the sale of 172 rental homes i..
PU
2022SANJOSE will build the Sansofi Residential Complex in Las Palmas de Gran Canaria
AQ
2022Metrovacesa S A : increases its net profit by 64.6% and announces the distribution of 159 ..
PU
2022Transcript : Metrovacesa S.A., Q3 2022 Earnings Call, Oct 27, 2022
CI
2022Metrovacesa S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
More news
Financials
Sales 2022 554 M 602 M 602 M
Net income 2022 30,9 M 33,5 M 33,5 M
Net Debt 2022 272 M 295 M 295 M
P/E ratio 2022 32,4x
Yield 2022 20,1%
Capitalization 1 019 M 1 106 M 1 106 M
EV / Sales 2022 2,33x
EV / Sales 2023 1,99x
Nbr of Employees 203
Free-Float 7,15%
Chart METROVACESA S.A.
Duration : Period :
Metrovacesa S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends METROVACESA S.A.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 6,73 €
Average target price 7,40 €
Spread / Average Target 9,88%
EPS Revisions
Managers and Directors
Jorge Pérez de Leza Eguiguren Chief Executive Officer & Director
Borja Tejada Rendón-Luna Chief Financial Officer
Ignacio Moreno Martínez Chairman
Eduardo Carreño Chief Operating Officer
Beatriz Puente Ferreras Independent Director
Sector and Competitors
1st jan.Capi. (M$)
METROVACESA S.A.5.65%1 124
CHINA VANKE CO., LTD.2.09%30 607
VONOVIA SE18.53%22 541
VINHOMES11.04%9 696
DEUTSCHE WOHNEN SE10.23%9 442
VINGROUP10.04%9 085